Back

Comparative effectiveness and safety of non-vitamin K oral anticoagulants and warfarin in non-valvular atrial fibrillation - a cohort study in 3 Nordic countries

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 4 - Anticoagulant therapy Anticoagulants ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Soeren Paaske Johnsen

Department of Clinical Medicine, Aalborg (Denmark)

6 More presentations in this session

Presentation thumbnail
Effects of EDOXaban on the cellular and protein phase of coagulation in coronary artery disease patients on dual antiplatelet therapy with aspirin and clopidogrel: a randomized pharmacodynamic study
Professor D. Angiolillo (Jacksonville, US)
Abstract Slides
Presentation thumbnail
Anti-inflammatory effects of direct oral anticoagulants in patients with non-valvular atrial fibrillation: insights from 2216 patients in the DIRECT registry
Assistant Professor Y. Sotomi (Osaka, JP)
Abstract
Presentation thumbnail
Modifications of renal function in atrial fibrillation patients treated with different oral anticoagulants: a multicentre cohort study.
Associate Professor D. Pastori (Rome, IT)
Abstract Slides
Presentation thumbnail
Safety and efficacy of non-vitamin k antagonist oral anticoagulants in elderly patients with atrial fibrillation: systematic review and meta-analysis of 27 studies and 446,944 patients
Doctor A. Silverio (Salerno, IT)
Presentation thumbnail
Relationship between international normalized ratio variability, quality of anticoagulation control and outcomes in patients with atrial fibrillation: an AFFIRM post-hoc analysis
Associate Professor M. Proietti (Milan, IT)
Abstract

Access the full session

Session thumbnail
Poster Session 4 - Anticoagulant therapy

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019
You may be interested in
thumbnail
Congress Presentation
State-of-the-art lecture on pharmacotherapy for acute coronary syndromes
thumbnail
Webinar
Antithrombotic treatment for dual pathway inhibition in cardiovascular disease patients
thumbnail
Congress Presentation
Direct oral anticoagulants or warfarin in patients with left ventricular thrombus: a meta-analysis of randomized clinical trials

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources